On 22 December, Minister Khairy Jamaluddin announced that the government will spend RM2.05 billion to purchase vaccines for 26.5 million Malaysians. If every person receives two doses, that works out to approximately RM39/dose on average, which is a very reasonable price and appears globally competitive.
These vaccines are an important tool in our ability to fight the pandemic. Malaysia has done well to sign procurement agreements with several companies to deliver enough vaccines for 83% of our population. However, this important milestone is being overshadowed by questions regarding the transparency of prices for each individual company.
These demands for price transparency are reasonable, for public trust, vaccine confidence and anti-corruption reasons. As a health policies and global health expert, I am supportive of transparency and fair contract terms between low-and-middle-income countries (LMICs) and large and powerful multinational pharmaceuticals. That will improve health outcomes, reduce corruption and strengthen public trust.
However, price transparency for the vaccine is a highly- complex situation with two sides. We must consider both sides to understand why the Malaysian government can’t disclose the vaccine prices. Understanding both sides will show us how to improve the outcome, which is value-for-money procurement, no corruption and high public trust.
As a brief disclosure, I’m currently an independent consultant for health systems and policies. I do not own stocks in any company anywhere in the world, and I spent eight years working for a large pharmaceutical company (two years in medical affairs in Singapore and six years as Ethics and Compliance Director based in Dubai, Shanghai and Paris covering Eastern Europe, Middle East & Africa and China).
Firstly, we must consider the forces outside government control. Pharma companies have three major customers: governments (health ministries, hospitals or govt insurers), private entities (private hospitals, distributors or agents) and global organisations (e.g., UNICEF buys 2 billion vaccine doses/year).
Pharmas often ask their customers to sign non-disclosure agreements (NDAs), even if it's a large customer. The NDAs can cover areas like intellectual property, prices or commercial terms. It’s probable that these NDAs cover ex-factory prices (i.e. wholesale, but not retail prices) and other commercial terms such as Custom/Insurance/Freight (CIF) terms or mark-ups along the distribution chain.
Pharmas want the NDAs to preserve or enhance their advantage. One, keeping intellectual property and patents secret provides an advantage over their competitors. Two, keeping ex-factory prices secret enhances their negotiating strength with other buyers. This is especially true because multinational pharmas sell to countries with different levels of wealth. Three, keeping commercial terms (such as freight prices, insurance terms and mark-ups) secret provides another advantage over their competitors.
You may ask then, why would a customer sign NDAs? Firstly, there’s no clear disadvantage for a customer to sign an NDA. There’s only a clear advantage if all other customers stop signing all NDAs with every company. So far, there is no single actor in the world willing and able to convene this collective action. Two, the customer needs or wants the products made by pharma and is willing to sign an NDA.
NDAs could help pharma make more money. At this point, maybe you're angry at pharma. But we can't blame pharma because it’s only responding to global capitalism. Wall Street, pension funds & asset managers want higher profits to benefit shareholders, pensioners & investors. The average Malaysian can benefit too, if institutions like EPF, Khazanah, PNB and private asset managers invest in pharma.
Now you might say “pharma shouldn’t profit from disease” and this is a very reasonable statement. But the solution is not to solely blame pharma, but also to change the structural forces that compel pharma to act in certain ways. In other words, we must change the way global capitalism functions and how global health goods (like vaccines, medicines and oxygen) are managed, priced and governed. Then, we can have equitable outcomes for the poorest and most vulnerable people in the world.
But that’s a very big and complex conversation, and it should be done separately. This letter only speaks about Covid-19 vaccine prices & NDAs. At this point, we understand that the NDAs are outside our Govt's control.
Malaysia must comply with them, because we have no choice. Revealing the vaccine prices means that we break the NDA, and we could potentially lose our vaccines. It’s not just Malaysia under the NDA; even the European Commission (with 27 countries and 450 million people) signed an NDA with Pfizer.
But, although the government is under NDAs, the government cannot "hide" behind them. Transparency will increase vaccine confidence & public trust, which strengthens public health. There are several ways we can build trust and fight corruption, despite the NDAs.
Firstly, publicly announcing the overall vaccine cost is an excellent move. Kudos to Minister Khairy for this transparency. Secondly, Minister Khairy has the right instinct to offer to disclose more to relevant Parliamentary Select Committees and the Public Accounts Committee. In theory, individual MPs can sign NDAs to preserve the confidentiality of the disclosure, but they are responsible if leaks happen and we lose vaccines.
Thirdly, the government can commit to release the details of each contract at a pre-agreed date, for example “two years after signing the contract”. This is an easy clause to insert into a contract with any pharma. Fourthly, the government can release more non-price details today, for example the terms for logistics, indemnity, insurance and freight. These value-added services are not price-related and can be public information.
Fifthly, Malaysia needs long-term work to strengthen our own external reference pricing system (to benchmark prices against peer countries) and build our own domestic manufacturing capacity to reduce over-reliance on foreign entities. Finally, Malaysia must actively lead reforms of global health. Two specific examples are the governance & pricing of global public goods such as vaccines and medicines.
In summary, I personally do not support NDAs. However, I understand and accept the current realities of global health and the global capitalist system. Malaysia is a middle power with limited leverage in a global health and capitalist landscape that is tilted against low-and-middle-income countries.
That understanding will give us a firm foundation to mitigate the disadvantages of NDAs, while working hard to increase our own self-reliance and change the deep infrastructure of global health. In the case for NDAs and Covid-19 vaccine prices, although the government is bound by NDAs, it can still do a lot. It’s up to citizens to understand both sides of the landscape, and hold the government accountable where possible.
-----------------------------------------------------------------------------------------------------------------------------------------------
* Dr Khor Swee Kheng is a public health and health policies specialist. He is also an independent consultant for the World Health Organisation.
* The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the position of Astro AWANI.
Dr Khor Swee Kheng
Tue Dec 29 2020
Its not just Malaysia under the NDA; even the European Commission (with 27 countries and 450 million people) signed an NDA with Pfizer. - File Pic
Prabowo takes up Indonesian presidency, vows to tackle corruption, other issues
Prabowo officially became Indonesia's eighth president on Sunday morning after he was sworn in during a ceremony at Indonesia's parliament.
Nepal's Sherpas deserve more, says teenager who scaled world's 14 tallest peaks
Sherpas are known for climbing skills that make them the backbone of mountain expeditions.
Prabowo takes up Indonesian presidency, vows to tackle corruption, other issues
Indonesia's Prabowo Subianto on Sunday took over as president of the world's third-largest democracy, vowing to combat internal issues
Inside the underground lab in China tasked with solving a physics mystery
China will soon collect neutrino data, aiming to unravel one of particle physics' biggest mysteries.
Millions in Cuba still without power as major outage persists
Millions of Cubans remain without electricity because of a prolonged outage at the main power plants on the island, Anadolu Agency reported.
Surge in Gaza violence increases famine risk, monitor says
About 1.84 million people across the besieged Palestinian enclave are living through high levels of acute food insecurity.
Israel pounds Beirut and Gaza after rockets hit Israel's north
A drone was launched at Prime Minister Benjamin Netanyahu's holiday home.
Elon Musk promises to award $1 mil each day to a signer of his petition
He awarded a $1 million check to an attendee of his event in Pennsylvania aimed at rallying supporters behind Donald Trump.
Former special forces commander Prabowo to take up Indonesian presidency
Indonesia's Prabowo Subianto will take over as president of the world's third-largest democracy after sweeping the country's election with policies like free meals for school children
Father of Malaysian Islamic banking, Abdul Halim Ismail passes away
His dedication and pioneering spirit played an important role in shaping the journey of Bank Islam as well as leaving a lasting impact on the development of Malaysia's Islamic finance industry.
Zayn Malik postpones US tour dates after One Direction bandmate Liam Payne's death
Payne, 31, died on Wednesday after falling from a third-floor hotel room balcony in Buenos Aires, shocking fans of the boy band.
Why voters in a handful of swing states will decide the US presidential election
The contest will almost certainly be decided by just tens of thousands of voters a tiny fraction of the populace in a handful of states.
INSIGHT - Sudan's war risks 'lost generation' of children
A devastating crisis is unfolding in Sudan, where the most vulnerable members of society children are bearing the brunt of the violence.
Who is Prabowo Subianto, incoming president of Indonesia?
A wealthy ex-general with ties to Indonesia's popular outgoing president and its dictatorial past, looks set to be its next leader.
Trump says he would impose tariffs on China if China went into Taiwan
Republican presidential candidate Donald Trump said he would impose additional tariffs on China if China were to "go into Taiwan,"
Iran's supreme leader says Hamas leader's death will not halt 'Axis of Resistance'
The "Axis of Resistance", built up with years of Iranian support, includes Hamas, the Lebanese Hezbollah group, the Houthi movement in Yemen, and various Shi'ite groups in Iraq and Syria.
Putin says Russia willing to seek compromises between Iran and Israel
Russia is ready to help seek compromises between arch-foes Israel and Iran, President Vladimir Putin said on Friday, saying these would be difficult but possible.
What proposals will Russia push at the BRICS summit?
The proposal is also to establish a BRICS reinsurance company to allow uninterrupted shipment of goods and key commodities between members.
Indonesia's free meals plan in the spotlight as Prabowo readies for office
Prabowo calls the programme one of the main drivers of economic growth, eventually set to add an estimated 2.5 million jobs.
Astro AWANI's revamped English news website, AWANI International, launches on Oct 21
Astro AWANI's revamped English platform delivers in-depth global news and expert analysis to keep you informed on key developments.